DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $73,746,000 | -15.9% | 862,223 | -23.5% | 0.06% | -18.9% |
| Q4 2016 | $87,683,000 | +29.1% | 1,126,452 | +30.1% | 0.07% | +29.8% |
| Q3 2016 | $67,894,000 | -5.4% | 866,109 | +21.9% | 0.06% | -6.6% |
| Q2 2016 | $71,789,000 | +36.4% | 710,786 | +28.1% | 0.06% | +32.6% |
| Q1 2016 | $52,621,000 | +82.8% | 554,719 | +79.0% | 0.05% | +84.0% |
| Q4 2015 | $28,787,000 | -40.3% | 309,943 | -45.2% | 0.02% | +13.6% |
| Q3 2015 | $48,186,000 | +6.4% | 565,486 | +6.8% | 0.02% | -40.5% |
| Q2 2015 | $45,300,000 | -42.3% | 529,275 | -42.7% | 0.04% | -43.1% |
| Q1 2015 | $78,455,000 | -2.2% | 924,087 | -1.2% | 0.06% | -5.8% |
| Q4 2014 | $80,192,000 | -1.7% | 935,618 | -12.8% | 0.07% | -6.8% |
| Q3 2014 | $81,539,000 | -62.6% | 1,073,170 | -61.3% | 0.07% | -63.0% |
| Q2 2014 | $218,060,000 | -17.3% | 2,769,933 | -21.2% | 0.20% | -18.4% |
| Q1 2014 | $263,707,000 | -7.2% | 3,516,138 | -4.4% | 0.24% | -8.2% |
| Q4 2013 | $284,022,000 | +18.8% | 3,678,757 | +6.7% | 0.27% | +12.7% |
| Q3 2013 | $239,020,000 | -1.3% | 3,447,754 | -9.9% | 0.24% | -6.3% |
| Q2 2013 | $242,111,000 | – | 3,824,823 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |